Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg,1 Leslie Citrome,2 Christopher L Drake3 1Neurotrials Research, Atlanta, GA, USA; 2Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 3Thomas Roth Sleep Disorders and Research Center, Henry Ford Health System, Detroit, MI, USACorrespondenc...
Guardado en:
Autores principales: | Rosenberg R, Citrome L, Drake CL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f490083eeb1142abb967d7432bfdb646 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman JL, et al.
Publicado: (2016) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Brief behavioral treatment for patients with treatment-resistant insomnia
por: Wang J, et al.
Publicado: (2016) -
TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic
por: Michael A. Norred, et al.
Publicado: (2021) -
Impact Of Phenotypic Heterogeneity Of Insomnia On The Patients’ Response To Cognitive-Behavioral Therapy For Insomnia: Current Perspectives
por: Galbiati A, et al.
Publicado: (2019)